Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Sunflower Pharmaceutical Group Co.,Ltd

Market Cap 7.35B 1.09B 936M 861M 808M 1.52B 103B 1.53B 10.18B 3.98B 50.24B 4.07B 3.99B 174B P/E Ratio 2024
24.4x
P/E Ratio 2025 -33.6x
Enterprise Value 4.85B 717M 618M 569M 534M 1B 67.79B 1.01B 6.73B 2.63B 33.2B 2.69B 2.63B 115B EV / Sales 2024
2.87x
EV / Sales 2025 2.65x
Free-Float
42.64%
Yield 2024
2.44%
Yield 2025 1.35%
1 day+1.13%
1 week-1.49%
Current month-3.82%
1 month-6.88%
3 months-0.87%
6 months-16.91%
Current year-14.83%
1 week 11.9
Extreme 11.9
12.83
1 month 11.9
Extreme 11.9
13.49
Current year 11.7
Extreme 11.7
15.19
1 year 11.7
Extreme 11.7
17.17
3 years 11.7
Extreme 11.7
30.79
5 years 11.7
Extreme 11.7
31.48
10 years 11.7
Extreme 11.7
31.48
Manager TitleAgeSince
Chief Executive Officer 44 2019-01-06
Director of Finance/CFO 49 2021-12-05
Human Resources Officer 48 -
Director TitleAgeSince
Director/Board Member 66 2014-03-25
Director/Board Member 64 2017-09-25
Director/Board Member 44 2017-09-25
Date Insider Type Main position Quantity % Market Cap.
24-07-16Buy 500 0.0001%
20-01-21Sell

Director

246,300 0.0462%
19-12-31Sell 21,300 0.0040%
Change 5-day change 1-year change 3-year change Capi.($)
+1.13%-1.49%-20.43%-47.80% 1.07B
-0.89%+2.75%-11.24%-5.79% 13.34B
-0.48%-0.80%-32.34%-55.83% 5.06B
-2.83%-1.11%-8.96%-0.69% 4.79B
+1.40%+3.44%+9.71%-39.82% 3.88B
+1.23%-1.10%+14.64%-15.63% 3.86B
-0.55%-3.68%-2.00%-7.86% 3.69B
+0.83%+2.40%-9.36%-0.14% 3.18B
+2.10%+3.26%-6.10%-25.18% 2.37B
+0.72%-3.58%-11.25%+29.11% 1.73B
Average +0.27%+1.51%-7.73%-16.96% 4.3B
Weighted average by Cap. -0.22%+1.58%-8.27%-15.53%

Financials

2024 2025
Net sales 3.38B 499M 430M 396M 371M 697M 47.16B 704M 4.68B 1.83B 23.09B 1.87B 1.83B 79.91B 2.32B 342M 295M 272M 255M 479M 32.37B 484M 3.21B 1.25B 15.85B 1.29B 1.26B 54.85B
Net income 492M 72.7M 62.66M 57.67M 54.1M 102M 6.87B 103M 682M 266M 3.36B 273M 267M 11.64B -258M -38.09M -32.83M -30.22M -28.35M -53.25M -3.6B -53.78M -357M -140M -1.76B -143M -140M -6.1B
Net Debt -2.29B -338M -292M -268M -252M -473M -31.97B -478M -3.17B -1.24B -15.66B -1.27B -1.24B -54.17B -2.49B -368M -317M -292M -274M -515M -34.8B -520M -3.45B -1.35B -17.04B -1.38B -1.35B -58.97B
Logo Sunflower Pharmaceutical Group Co.,Ltd
Sunflower Pharmaceutical Group Co Ltd is a China-based company principally engaged in the research, development, manufacture and sale of Chinese patent drugs, chemical drugs, biopharmaceuticals and health products. The Company operates its businesses through three segments. The Headquarters Segment is responsible for investment management. The Pharmaceutical segment is mainly responsible for pharmaceutical production and sales. Other segment is mainly responsible for the production of packaging materials and the cultivation and research of Chinese herbal medicines. The Company’s main products include Weikangling capsules, liver tablets, hyperactivity cough oral liquid for children use, pediatric Huatanzhike particles, Kangfu anti-inflammatory suppository and pediatric paracetamol particles, among others. The Company distributes its products in the domestic market.
Employees
5,025
Date Price Change Volume
26-06-14 12.58 ¥ +1.13% 4,823,259
26-06-12 12.44 ¥ +2.30% 6,821,623
26-06-11 12.16 ¥ -2.33% 4,034,100
26-06-10 12.45 ¥ -0.80% 3,594,200
26-06-09 12.55 ¥ -1.49% 4,605,630

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002737 Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!